{
  "id": 3535,
  "text": "Radiother Oncol 103, 113-122 (2012).1511.Sugiyama, T., et al.Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.Br J Cancer 81, 95-98 (1999).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Radiother Oncol 103, 113-122 (2012).1511.Sugiyama, T., et al.Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.Br J Cancer 81, 95-98 (1999).\n\n<question>: ",
  "ChatGPT_response_0": "联合伊立替康和顺铂作为新辅助化疗在治疗宫颈癌方面显示出一定的疗效。研究表明伊立替康和顺铂的结合化疗可以作为局部晚期宫颈癌的新辅助化疗方法。这种联合治疗方案可能有助于减少肿瘤的体积，并提高手术的可行性和治疗效果。然而，对于个体患者的具体疗效还需结合临床情况进行评估，因此在治疗过程中应该根据具体情况进行选择合适的治疗方案。",
  "query": " 试问在治疗宫颈癌方面，联合伊立替康和顺铂作为新辅助化疗的疗效如何？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>:  试问在治疗宫颈癌方面，联合伊立替康和顺铂作为新辅助化疗的疗效如何？\n\n<reference text>: Radiother Oncol 103, 113-122 (2012).1511.Sugiyama, T., et al.Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer.Br J Cancer 81, 95-98 (1999).\n\n<reply>: ",
  "response": "联合伊立替康和顺铂作为新辅助化疗在治疗宫颈癌方面显示出一定的疗效。研究表明伊立替康和顺铂的结合化疗可以作为局部晚期宫颈癌的新辅助化疗方法。这种联合治疗方案可能有助于减少肿瘤的体积，并提高手术的可行性和治疗效果。然而，对于个体患者的具体疗效还需结合临床情况进行评估，因此在治疗过程中应该根据具体情况进行选择合适的治疗方案。"
}